• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2刺突蛋白:开发新型冠状病毒肺炎疫苗的位点特异性断点

SARS-CoV-2 spike protein: Site-specific breakpoints for the development of COVID-19 vaccines.

作者信息

Velusamy Palaniyandi, Kiruba Kannan, Su Chia-Hung, Arun Viswanathan, Anbu Periasamy, Gopinath Subash C B, Vaseeharan Baskaralingam

机构信息

Research and Development Wing, Central Research Laboratory, Sree Balaji Medical College and Hospital, Bharath Institute of Higher Education and Research (BIHER), Chennai- 600 044, TN, India.

Department of Biotechnology, University of Madras, Guindy Campus, Chennai 600 025, TN, India.

出版信息

J King Saud Univ Sci. 2021 Dec;33(8):101648. doi: 10.1016/j.jksus.2021.101648. Epub 2021 Oct 19.

DOI:10.1016/j.jksus.2021.101648
PMID:34690467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8523302/
Abstract

SARS-CoV2 is a member of human coronaviruses and is the causative agent of the present pandemic COVID-19 virus. In order to control COVID-19, studies on viral structure and mechanism of infectivity and pathogenicity are sorely needed. The spike (S) protein is comprised of S1 & S2 subunits. These spike protein subunits enable viral attachment by binding to the host cell ACE-2 (angiotensin converting enzyme-2) receptor, thus facilitating the infection. During viral entry, one of the key steps is the cleavage of the S1-S2 spike protein subunits surface TMPRSS2 (transmembrane protease serine 2) and results in viral infection. Hence, the S-protein is critical for the viral attachment and penetration into the host. The rapid advancement of our knowledge on the structural and functional aspects of the spike protein could lead to development of numerous candidate vaccines against SARS-CoV2. Here the authors discuss about the structure of spike protein and explore its related functions. Our aim is to provide a better understanding that may aid in fighting against CoVID-19 and its treatment.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV2)是人类冠状病毒的一种,是当前大流行的新型冠状病毒肺炎(COVID-19)病毒的病原体。为了控制COVID-19,迫切需要对病毒结构以及感染性和致病性机制进行研究。刺突(S)蛋白由S1和S2亚基组成。这些刺突蛋白亚基通过与宿主细胞血管紧张素转换酶2(ACE-2)受体结合实现病毒附着,从而促进感染。在病毒进入过程中,关键步骤之一是S1-S2刺突蛋白亚基被跨膜丝氨酸蛋白酶2(TMPRSS2)切割,进而导致病毒感染。因此,S蛋白对于病毒附着和进入宿主至关重要。我们对刺突蛋白结构和功能方面的认识迅速进步,这可能会促使研发出多种针对SARS-CoV2的候选疫苗。在此,作者们讨论了刺突蛋白的结构并探究了其相关功能。我们的目的是提供更深入的理解,以助力抗击COVID-19及其治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d8/8523302/52105336768b/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d8/8523302/4b39ae492ddd/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d8/8523302/c4adcd533cf6/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d8/8523302/056ace93593f/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d8/8523302/52105336768b/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d8/8523302/4b39ae492ddd/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d8/8523302/c4adcd533cf6/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d8/8523302/056ace93593f/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d8/8523302/52105336768b/gr3_lrg.jpg

相似文献

1
SARS-CoV-2 spike protein: Site-specific breakpoints for the development of COVID-19 vaccines.严重急性呼吸综合征冠状病毒2刺突蛋白:开发新型冠状病毒肺炎疫苗的位点特异性断点
J King Saud Univ Sci. 2021 Dec;33(8):101648. doi: 10.1016/j.jksus.2021.101648. Epub 2021 Oct 19.
2
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.弗林蛋白酶和 TMPRSS2 在 SARS-CoV-2 感染中的独特作用。
J Virol. 2022 Apr 27;96(8):e0012822. doi: 10.1128/jvi.00128-22. Epub 2022 Mar 28.
3
Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein.金属蛋白酶依赖和 TMPRSS2 非依赖的 SARS-CoV-2 细胞表面进入途径需要 Spike 蛋白的 S2 结构域和弗林蛋白酶裂解位点。
mBio. 2022 Aug 30;13(4):e0051922. doi: 10.1128/mbio.00519-22. Epub 2022 Jun 16.
4
SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.SARS-CoV-2 刺突蛋白的弗林蛋白酶裂解位点和 S2'碱性残基以宿主细胞依赖的方式调节进入过程。
J Virol. 2022 Jul 13;96(13):e0047422. doi: 10.1128/jvi.00474-22. Epub 2022 Jun 9.
5
Understanding the role of conserved proline and serine residues in the SARS-CoV-2 spike cleavage sites in the virus entry, fusion, and infectivity.了解SARS-CoV-2刺突蛋白裂解位点中保守的脯氨酸和丝氨酸残基在病毒进入、融合和感染性中的作用。
3 Biotech. 2023 Oct;13(10):323. doi: 10.1007/s13205-023-03749-y. Epub 2023 Aug 30.
6
The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.TMPRSS2 抑制剂那法莫司他可降低 COVID-19 小鼠模型中的 SARS-CoV-2 肺部感染。
mBio. 2021 Aug 31;12(4):e0097021. doi: 10.1128/mBio.00970-21. Epub 2021 Aug 3.
7
Structural Basis for the Understanding of Entry Inhibitors against SARS Viruses.SARS 病毒进入抑制剂作用机制的结构基础。
Curr Med Chem. 2022;29(4):666-681. doi: 10.2174/0929867328666210514122418.
8
Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies.针对 SARS-CoV-2 细胞进入机制的靶向治疗策略:体外和体内研究的系统评价。
J Cell Physiol. 2021 Apr;236(4):2364-2392. doi: 10.1002/jcp.30032. Epub 2020 Sep 9.
9
The structural basis of accelerated host cell entry by SARS-CoV-2†.SARS-CoV-2 加速宿主细胞进入的结构基础。
FEBS J. 2021 Sep;288(17):5010-5020. doi: 10.1111/febs.15651. Epub 2020 Dec 14.
10
The old but new: Can unfractioned heparin and low molecular weight heparins inhibit proteolytic activation and cellular internalization of SARS-CoV2 by inhibition of host cell proteases?旧药新用:肝素和低分子肝素能否通过抑制宿主细胞蛋白酶来抑制 SARS-CoV2 的蛋白水解激活和细胞内吞?
Med Hypotheses. 2020 Sep;142:109743. doi: 10.1016/j.mehy.2020.109743. Epub 2020 Apr 20.

引用本文的文献

1
Diagnostic techniques for critical respiratory infections: Update on current methods.重症呼吸道感染的诊断技术:当前方法的更新
Heliyon. 2023 Aug 5;9(8):e18957. doi: 10.1016/j.heliyon.2023.e18957. eCollection 2023 Aug.
2
Ketogenic Diet and Ketone Bodies as Clinical Support for the Treatment of SARS-CoV-2-Review of the Evidence.生酮饮食和酮体作为治疗 SARS-CoV-2 的临床支持——证据回顾。
Viruses. 2023 May 27;15(6):1262. doi: 10.3390/v15061262.
3
Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43.

本文引用的文献

1
Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice.植物表达的 SARS-CoV-2 糖基化和体内去糖基化受体结合域蛋白在小鼠中诱导强烈的中和反应。
Viruses. 2021 Aug 12;13(8):1595. doi: 10.3390/v13081595.
2
Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity.Biovacc-19:一种基于对新冠病毒(SARS-CoV-2)感染性一般作用机制分析而研发的新冠疫苗候选物。
QRB Discov. 2020 Jun 2;1:e6. doi: 10.1017/qrd.2020.8. eCollection 2020.
3
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
硫酸乙酰肝素和依诺肝素在 HCoV-229E 刺突蛋白的界面相互作用,但不与 HCoV-OC43 相互作用。
Viruses. 2023 Mar 1;15(3):663. doi: 10.3390/v15030663.
4
Novel Affibody Molecules Specifically Bind to SARS-CoV-2 Spike Protein and Efficiently Neutralize Delta and Omicron Variants.新型亲和体分子特异性结合 SARS-CoV-2 刺突蛋白并有效中和德尔塔和奥密克戎变异株。
Microbiol Spectr. 2023 Feb 14;11(1):e0356222. doi: 10.1128/spectrum.03562-22. Epub 2022 Dec 13.
5
Kinetics of Drug Molecule Interactions with a Newly Developed Nano-Gold-Modified Spike Protein Electrochemical Receptor Sensor.新型纳米金修饰刺突蛋白电化学受体传感器中药物分子相互作用的动力学研究。
Biosensors (Basel). 2022 Oct 17;12(10):888. doi: 10.3390/bios12100888.
SARS-CoV-2 刺突 RBD 中的 V367F 突变增强了与人类 ACE2 受体的结合亲和力,从而提高了病毒的感染性。
J Virol. 2021 Jul 26;95(16):e0061721. doi: 10.1128/JVI.00617-21.
4
Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.N501Y 型严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)刺突蛋白与血管紧张素转换酶 2(ACE2)及两种强效中和抗体复合物的冷冻电镜结构
PLoS Biol. 2021 Apr 29;19(4):e3001237. doi: 10.1371/journal.pbio.3001237. eCollection 2021 Apr.
5
Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients.来自 1051 名 COVID-19 患者的 SARS-CoV-2 刺突蛋白线性表位图谱。
Cell Rep. 2021 Mar 30;34(13):108915. doi: 10.1016/j.celrep.2021.108915. Epub 2021 Mar 12.
6
COVID-19 vaccines: modes of immune activation and future challenges.COVID-19 疫苗:免疫激活模式和未来挑战。
Nat Rev Immunol. 2021 Apr;21(4):195-197. doi: 10.1038/s41577-021-00526-x.
7
Synthesis and immunogenicity assessment of a gold nanoparticle conjugate for the delivery of a peptide from SARS-CoV-2.一种用于递送来自严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的肽的金纳米颗粒缀合物的合成及免疫原性评估
Nanomedicine. 2021 Jun;34:102372. doi: 10.1016/j.nano.2021.102372. Epub 2021 Mar 2.
8
Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity.刺突蛋白融合环控制 SARS-CoV-2 的融合性和感染性。
J Struct Biol. 2021 Jun;213(2):107713. doi: 10.1016/j.jsb.2021.107713. Epub 2021 Mar 1.
9
Human SARS CoV-2 spike protein mutations.人类严重急性呼吸系统综合征冠状病毒 2 刺突蛋白突变。
Proteins. 2021 May;89(5):569-576. doi: 10.1002/prot.26042. Epub 2021 Jan 17.
10
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach.mRNA 疫苗预防 COVID-19 疾病和报告的过敏反应:当前证据和建议方法。
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1423-1437. doi: 10.1016/j.jaip.2020.12.047. Epub 2020 Dec 31.